In 2016, the CMA fined Pfizer and Flynn a record 90 million pounds ($125 million) for the price hike. However, the companies in 2018 won an appeal against the penalty, and the Competition Appeal Tribunal referred the matter back to the CMA.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3CgU7pB
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Pfizer epilepsy drug prices were 'unfairly high,' UK review finds
https://ift.tt/eA8V8J
No comments:
Post a Comment